Skip to main content

Congratulations on 2020 Nobel Prize in Chemistry

Posted on by Dr. Francis Collins

Congratulations to Jennifer Doudna and Emmanuelle Charpentier on sharing the 2020 Nobel Prize in Chemistry “for the development of a method for genome editing.” Doudna, a biochemist with the University of California, Berkeley and a genome editing pioneer, has received continuous NIH funding since 1997. Charpentier is a French microbiologist and a fellow genome editing pioneer with the Max Planck Institute for Infection Biology, Berlin, Germany. Here, I am with Doudna on December 12, 2018 during a U. S. Senate NIH Caucus Meeting on CRISPR and Gene Editing. Credit: Berkeley News


  • hellopk says:

    Congratulations for Nobel Prize.

  • Mike Hasan says:

    Great News. Liked it…

  • John Hasty says:

    Great informative post, thanks to all.

  • John H says:

    I had discovered one of the best way to isolate and study the technical terms used in a procedure like CRISPR is to search the patent legalities. These legal sites do a great job of stating the individual terms for products involved in the experiments. In the midst of the recent talks and celebration centered around the CRISPR-Cas9 Nobel Prize I had on question “ from the audience” that was not addressed. I wondered why! All of which being me to the question of does the US Government get any financial reimbursements or royalty payments from supported research?


      They typically gain the “lack of liability” that comes with such a thing.

      That’s how its played out with IARPA / DARPA funded projects through the military.

      The private sector is more so, “taking” the investment made into them. And, subsequently into the American people.

      Just so, happens the “private” sector is sometimes better suited to work as a “services” provider. Than, our public sector.

      Who may be best suited to the colossal half-centaury long R&D processes. We keep earning so many Nobel’s for.

  • F. says:

    Congratulations for Nobel Prize.

Leave a Comment